Impact of Axillary Dissection on Clinical Outcomes of Breast Cancer Surgery

Abstract

We studied 26,290 women with early-stage breast cancer aged >25 in 1983-1993 who received BCS, using data from the Surveillance, Epidemiology and End Results Program and Medicare. Twenty seven percent of women aged >25 receiving BCS did not receive axillary dissection, most of whom (74%) were age >65. Women receiving BCS with axillary dissection had lower 7-year breast cancer- specific mortality than did those without dissection (hazard ratio--0.53, 95% confidence interval: 0.44-0.63). We found an interaction between receipt of axillary dissection and radiotherapy on survival of older women after BCS. Women who received either axillary dissection or radiotherapy experienced similar survivals to those who received both axillary dissection and radiation, while women who received neither treatment experienced poorer survival (hazard ratio--i .76, 1.23-2.52), after controlling for demographics, tumor size and comorbidity. In conclusion, the combination of no axillary dissection plus no radiation after BCS is associated with an unacceptably high level of deaths from breast cancer. The lack of improvement in the past two decades in survival of older women with breast cancer may be explained in part by the increasing use of treatments that do not address potential tumor in axillary nodes.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Jun 01, 2000
Accession Number
ADA382511

Entities

People

  • Xianglin Du

Organizations

  • University of Texas Medical Branch

Tags

DTIC Thesaurus Topics

  • Biomedical Research
  • Breast Cancer
  • Chemotherapy
  • Comorbidity
  • Demography
  • Health Services
  • Intervals
  • Laboratory Animals
  • Materials
  • Medicare
  • Neoplasms
  • Radiation
  • Radiotherapy
  • Recombinant Dna
  • Surgery
  • Survival
  • Therapy

Fields of Study

  • Medicine

Readers

  • Chemistry (specifically Chemical Fluorescence)
  • Mental Health of Military Veterans with Posttraumatic Stress Disorder (PTSD): Risk Factors, Prevalence, Symptoms, and Treatment.
  • Oncology